Conivaptan and its role in the treatment of hyponatremia
Jalal K Ghali,1 Jareer O Farah,2 Suleiman Daifallah,3 Hassan A Zabalawi,4 Hammam D Zmily51Detroit Medical Center, Detroit, MI, USA; 2Wayne State University/Detroit Medical Center, Detroit, MI, USA; 3John D Dingell VA Medical Center, Detroit, MI, USA; 4,5Wayne State University/Detroit Medical Center,...
Saved in:
Main Authors: | Jalal K Ghali (Author), Jareer O Farah (Author), Suleiman Daifallah (Author), et al (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Conivaptan: a step forward in the treatment of hyponatremia?
by: Su Su Hline, et al.
Published: (2008) -
Dose comparison of conivaptan (Vaprisol®) in patients with euvolemic or hypervolemic hyponatremia – efficacy, safety, and pharmacokinetics
by: Palmer BF, et al.
Published: (2016) -
New Topics in Vasopressin Receptors and Approach to Novel Drugs: Research and Development of Conivaptan Hydrochloride (YM087), a Drug for the Treatment of Hyponatremia
by: Yukinori Arai, et al.
Published: (2009) -
Efficacy of vaptans for correction of postoperative hyponatremia: A comparison between single intravenous bolus conivaptan vs oral tolvaptan
by: Sunil Rajan, et al.
Published: (2018) -
Pharmacokinetics of conivaptan use in patients with severe hepatic impairment
by: Marbury T, et al.
Published: (2017)